|
Volumn 4, Issue 1, 2007, Pages 12-16
|
P-glycoprotein inhibitory activity of two phenolic compounds, (-)-syringaresinol and tricin from Sasa borealis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DAUNORUBICIN;
DOXORUBICIN;
GLYCOPROTEIN P INHIBITOR;
PHENOL DERIVATIVE;
PLANT EXTRACT;
SASA BOREALIS EXTRACT;
SYRINGARESINOL;
TRICIN;
UNCLASSIFIED DRUG;
VERAPAMIL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER INHIBITION;
CANCER RESISTANCE;
CELL STRAIN MCF 7;
CONTROLLED STUDY;
DRUG ACCUMULATION;
DRUG CYTOTOXICITY;
DRUG IDENTIFICATION;
DRUG ISOLATION;
DRUG POTENCY;
DRUG POTENTIATION;
DRUG STRUCTURE;
HUMAN;
HUMAN CELL;
IC 50;
NONHUMAN;
PHYTOCHEMISTRY;
SASA;
SASA BOREALIS;
STRUCTURE ACTIVITY RELATION;
BAMBUSA;
CELL LINE, TUMOR;
CHROMATOGRAPHY, THIN LAYER;
FLAVONOIDS;
FURANS;
HUMANS;
LIGNANS;
P-GLYCOPROTEIN;
SPECTRUM ANALYSIS;
POACEAE;
SASA;
|
EID: 33846698320
PISSN: 16121872
EISSN: 16121880
Source Type: Journal
DOI: 10.1002/cbdv.200790001 Document Type: Article |
Times cited : (44)
|
References (19)
|